Table 2.
Characteristics associated with suPAR levels in participants with ADPKD
| Variables | suPAR, per 100% Increase | |
|---|---|---|
| β, P Value | 95% CI | |
| Age, per 10 yr | 0.06, 0.029 | 0.01 to 0.11 |
| Male | −0.29, <0.001 | −0.36 to −0.21 |
| White | 0.09, 0.07 | −0.01 to 0.19 |
| Body mass index, per kg/m2 | 0.00, 0.22 | −0.00 to 0.01 |
| Hypertension | 0.00, 0.97 | −0.12 to 0.13 |
| ACEi or ARB use | 0.02, 0.70 | −0.09 to 0.13 |
| eGFR, per 5 ml/min per 1.73 m2 | −0.03, <0.001 | −0.04 to −0.02 |
| htTKV, per 100 ml/m | 0.02, <0.001 | 0.01 to 0.03 |
Values in bold are statistically significant. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.